Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study

Por Mamdani, Muhammad, Juurlink, David N, Kopp, Alex, Naglie, Gary, Austin, Peter C, Laupacis, Andreas
Publicado em 2004

Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario

Por Mamdani, Muhammad, Warren, Leanne, Kopp, Alex, Paterson, J. Michael, Laupacis, Andreas, Bassett, Ken, Anderson, Geoffrey M.
Publicado em 2006

Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease?

Por Dhalla, Irfan A., Mamdani, Muhammad M., Simor, Andrew E., Kopp, Alex, Rochon, Paula A., Juurlink, David N.
Publicado em 2006

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone

Por Dhalla, Irfan A., Mamdani, Muhammad M., Sivilotti, Marco L.A., Kopp, Alex, Qureshi, Omar, Juurlink, David N.
Publicado em 2009

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

Por Mamdani, Muhammad, Rochon, Paula A, Juurlink, David N, Kopp, Alex, Anderson, Geoffrey M, Naglie, Gary, Austin, Peter C, Laupacis, Andreas
Publicado em 2002

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

Por Juurlink, David N., Gomes, Tara, Ko, Dennis T., Szmitko, Paul E., Austin, Peter C., Tu, Jack V., Henry, David A., Kopp, Alex, Mamdani, Muhammad M.
Publicado em 2009